RESEARCHER PROFILE
Professor Kristofer Thurecht, Deputy Director of Research & Senior
Group leader, Australian Institute for Bioengineering and Nanotechnology,
University of Queensland, Australia
Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.
Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.
Professor Thurecht undertook his PhD at the University of Queensland and decided he wanted to go to the University of Nottingham in the UK, where his mentors pushed him into the new field of nanomedicine. On returning to Australia he brought his ideas on nanomedicine back to the University of Queensland, where he works today.
His research focuses on understanding how nanomedicines behave in biological environments using high-end imaging infrastructure, with a focus on radiopharmaceutical research to establish next generation drugs for diseases like cancer.
Nanomedicine research, particularly in the field of cancer treatment, has the potential to revolutionise traditional medicine and improve the quality of life for those suffering from the disease. Radiopharmaceuticals and molecular imaging are revolutionising cancer treatment by providing targeted therapies and precise drug delivery, showing potential for groundbreaking advancements in the field.
Radiopharmaceuticals utilise radiation as a potent therapy for treating diseases, particularly cancer. As Professor Thurecht states, the development of radiopharmaceutical for cancer treatment is a promising and innovative field in nanomedicine.
Outside of research Professor Thurecht enjoys fishing and boating with family on weekends.
You Might also like
-
Health impacts of donor milk for pre-term babies
Professor Alice Rumbold is Theme Leader of SAHMRI Women and Kids, managing a multidisciplinary research team focussed on improving health outcomes for women, babies and families. She also holds an affiliate position as a Research Leader within the Robinson Research Institute at the University of Adelaide.
An epidemiologist and health services researcher, she is internationally renowned for her leadership of large-scale clinical trials, epidemiological studies and systematic review activities to improve perinatal and reproductive health care. She is passionate about improving health outcomes for women and babies, particularly those experiencing vulnerability. Her current research interests include preterm birth, breastfeeding, human milk banking and infertility
-
Visceral pain and the gut-brain axis
Professor Stuart Brierley is Director of the Visceral Pain Research Group, Director of the Hopwood Centre for Neurobiology, and Theme co-Leader of Lifelong Health at the South Australian Health and Medical Research Institute (SAHMRI).
Prof Brierley is an international expert on the ‘gut-brain axis’ and chronic visceral pain mechanisms. Current investigations are on a individual cell type called the enterochromaffin cell, and it helps signal pain and anxiety from the gastrointestinal tract to the brain.
-
Benefits of prehabilitation ahead of surgery
Dr Matthew Wallen PhD, AES, AEP is a Senior Research Fellow in Cancer Survivorship, the Deputy Lead of the Cancer Survivorship Program, and a Senior Lecturer in Exercise Science and Clinical Exercise Physiology within the College of Nursing and Health Sciences at Flinders University, in South Australia. His clinical interest focuses on improving outcomes for people requiring major surgery, specifically (1) lifestyle interventions, including exercise, nutritional, and psychological support to improve the health and wellbeing of people prior to surgery, termed ‘prehabilitation’, (2) novel physical function assessments aimed at identifying people at risk of treatment-related complications, and (3) implementation of new models of care in cancer.